In a report released today, Steve Scala from TD Cowen maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price ...

The stock's fall snapped a two-day winning streak.

We recently published a list of Billionaire Ken Fisher’s Top 13 Growth Stock Picks. In this article, we are going to take a ...

"Lilly is committed to supporting initiatives that foster the translation of scientific evidence into clinical practice and improve patient outcomes," said Kara Clinton, Senior Vice President of ...

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

Eli Ellis, the South Carolina signee, led his team, YNG Dreamerz, to their second win in the finals of the OTE Pokemon Playoffs against Meleek Thomas' City Reapers on Saturday. Ellis called the ...

(Reuters) -Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico in 2025, Chief Financial Officer Lucas Montarce said on Monday at the ...

Investor hopes were similarly high, so it's little wonder those folks were bearish on Novo Nordisk. They also punished fellow obesity drug developers like Eli Lilly in a sympathy sell-off.

It's very much my pleasure to welcome members of Lilly's leadership team to be here ... natural headwind that we see that is in the mid to high single-digit price erosion. The last two years ...

Presiding over the upward trajectory of Eli Lilly over the last eight years has been paying off nicely for CEO David Ricks. In 2024, his compensation package grew to $29.2 million, according to ...

March 10 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and Mexico in the second half of ...